Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation
Clinical trial NCT01536392 · COMPLETED
Trial details
- NCT number
- NCT01536392
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2019-10-03
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.